X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (135229) 135229
Book Review (18511) 18511
Newsletter (14630) 14630
Publication (9674) 9674
Newspaper Article (3357) 3357
Patent (1144) 1144
Book Chapter (1122) 1122
Conference Proceeding (608) 608
Magazine Article (442) 442
Dissertation (280) 280
Book / eBook (181) 181
Trade Publication Article (73) 73
Reference (52) 52
Web Resource (52) 52
Transcript (43) 43
Data Set (17) 17
Paper (15) 15
Government Document (6) 6
Streaming Video (4) 4
Journal / eJournal (3) 3
Presentation (3) 3
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (98170) 98170
animals (57646) 57646
humans (53354) 53354
male (44878) 44878
fatty acids (37540) 37540
female (31446) 31446
fatty liver (26549) 26549
rats (24793) 24793
liver (24100) 24100
research (19408) 19408
mice (18622) 18622
liver - metabolism (18502) 18502
biochemistry & molecular biology (18405) 18405
metabolism (18308) 18308
obesity (16136) 16136
lipids (15753) 15753
adult (15402) 15402
physiological aspects (14920) 14920
middle aged (14389) 14389
diet (14306) 14306
insulin resistance (13398) 13398
analysis (12396) 12396
nutrition & dietetics (12155) 12155
endocrinology & metabolism (11740) 11740
insulin-resistance (11450) 11450
fatty acids - metabolism (11150) 11150
lipid metabolism (10699) 10699
gastroenterology & hepatology (10032) 10032
liver diseases (9829) 9829
risk factors (9646) 9646
glucose (9188) 9188
rodents (9187) 9187
cholesterol (9045) 9045
inflammation (9016) 9016
gene expression (8890) 8890
metabolic syndrome (8861) 8861
oxidative stress (8772) 8772
proteins (8702) 8702
insulin (8532) 8532
medical research (8424) 8424
diabetes (8305) 8305
cell biology (7883) 7883
health aspects (7753) 7753
fatty-acids (7702) 7702
liver - pathology (7659) 7659
liver - drug effects (7503) 7503
aged (7408) 7408
medicine, experimental (7380) 7380
physiology (7188) 7188
enzymes (7114) 7114
fatty liver-disease (7018) 7018
expression (7006) 7006
non-alcoholic fatty liver disease (6884) 6884
abridged index medicus (6839) 6839
pharmacology & pharmacy (6723) 6723
triglycerides (6701) 6701
nutrition (6646) 6646
disease (6509) 6509
unsaturated fatty acids (6055) 6055
reports (6038) 6038
mice, inbred c57bl (6033) 6033
article (6014) 6014
steatosis (5982) 5982
food science & technology (5834) 5834
fatty liver - pathology (5749) 5749
fatty acids, nonesterified - blood (5669) 5669
gene-expression (5663) 5663
triglycerides - blood (5359) 5359
type 2 diabetes (5357) 5357
medicine (5275) 5275
adipose-tissue (5227) 5227
fibrosis (5175) 5175
research article (5069) 5069
nonalcoholic steatohepatitis (5041) 5041
care and treatment (5000) 5000
hepatic steatosis (4977) 4977
body weight (4955) 4955
multidisciplinary sciences (4935) 4935
oxidation-reduction (4826) 4826
fatty liver - metabolism (4818) 4818
rats, wistar (4809) 4809
dietary supplements (4657) 4657
liver - enzymology (4632) 4632
life sciences (4618) 4618
rats, sprague-dawley (4614) 4614
triglycerides - metabolism (4584) 4584
time factors (4568) 4568
pregnancy (4517) 4517
disease models, animal (4493) 4493
medicine, research & experimental (4438) 4438
blood glucose - metabolism (4422) 4422
cancer (4413) 4413
insulin - blood (4361) 4361
steatohepatitis (4337) 4337
studies (4334) 4334
omega-3 fatty acids (4295) 4295
metabolites (4187) 4187
oxidation (4161) 4161
glucose - metabolism (4101) 4101
apoptosis (4086) 4086
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (71) 71
Online Resources - Online (19) 19
UofT at Mississauga - Stacks (10) 10
Engineering & Comp. Sci. - Stacks (5) 5
UofT at Scarborough - Stacks (5) 5
Chemistry (A D Allen) - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Gerstein Science - Theses (1) 1
Royal Ontario Museum - May be requested (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
University Archives - Archives (1) 1
UofT at Mississauga - Missing (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (147241) 147241
German (1804) 1804
French (1059) 1059
Chinese (998) 998
Russian (952) 952
Japanese (937) 937
Danish (671) 671
Spanish (650) 650
Italian (510) 510
Korean (507) 507
Polish (218) 218
Portuguese (202) 202
Swedish (163) 163
Hungarian (104) 104
Czech (98) 98
Ukrainian (61) 61
Dutch (57) 57
Turkish (55) 55
Romanian (51) 51
Persian (48) 48
Slovak (43) 43
Bulgarian (33) 33
Norwegian (19) 19
Croatian (18) 18
Serbian (13) 13
Icelandic (10) 10
Finnish (9) 9
Bosnian (4) 4
Hebrew (4) 4
Lithuanian (4) 4
Indonesian (3) 3
Slovenian (3) 3
Catalan (2) 2
Arabic (1) 1
Estonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hepatology, ISSN 0270-9139, 04/2017, Volume 65, Issue 4, pp. 1165 - 1180
Journal Article
Gut, ISSN 0017-5749, 03/2012, Volume 61, Issue 3, pp. 416 - 426
ObjectiveMonocyte chemoattractant protein-1 (MCP-1, CCL2), the primary ligand for chemokine receptor C–C chemokine receptor 2 (CCR2), is increased in livers of... 
FIBROSIS | STEATOSIS | INSULIN-RESISTANCE | INFLAMMATION | BONE-MARROW | DISEASE | MONOCYTE SUBSETS | MICE | SPIEGELMER | GASTROENTEROLOGY & HEPATOLOGY | CCR2 | Liver - pathology | Carbon Tetrachloride | Liver Cirrhosis, Experimental - etiology | Bone Marrow Cells - physiology | Male | Chemical and Drug Induced Liver Injury, Chronic - drug therapy | Liver Cirrhosis, Experimental - prevention & control | Non-alcoholic Fatty Liver Disease | Chemokine CCL2 - physiology | Bone Marrow Cells - drug effects | Chemical and Drug Induced Liver Injury - pathology | Chemical and Drug Induced Liver Injury, Chronic - complications | Macrophages - physiology | Aptamers, Nucleotide - pharmacology | Drug Evaluation, Preclinical - methods | Acute Disease | Cytokines - metabolism | Liver - metabolism | Mice, Inbred C57BL | Cells, Cultured | Fatty Liver - prevention & control | Aptamers, Nucleotide - therapeutic use | Chemotaxis - drug effects | Chemical and Drug Induced Liver Injury, Chronic - pathology | Disease Progression | Fatty Liver - drug therapy | Animals | Chemical and Drug Induced Liver Injury - complications | Chemical and Drug Induced Liver Injury - drug therapy | Macrophages - drug effects | Mice | Chemokine CCL2 - antagonists & inhibitors | Fatty Liver - etiology | Care and treatment | Liver diseases | Fibrosis | Models | Research | Macrophages | Chemokine receptors | Studies | Cytokines | Polyethylene glycol | Rodents | Liver | Clinical trials | Tumor necrosis factor-TNF | Inflammation | Diabetes | Metabolic disorders | Chemokines | Immunohistochemistry | CC chemokine receptors | Flow cytometry | Animal models | Leukocyte migration | RNA | Carbon tetrachloride | Oligonucleotides | Blood | Metastases | Interleukin 6 | Fatty liver | CCR2 protein | Degeneration | Lipogenesis | Digestive tract | steatosis | Injuries | Triglycerides | CCL4 protein | Chemotaxis | Diets | Monocytes | gamma -Interferon | Monocyte chemoattractant protein 1 | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2012, Volume 122, Issue 8, pp. 2884 - 2897
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2012, Volume 122, Issue 8, pp. 2871 - 2883
miR-122, an abundant liver-specific microRNA (miRNA), regulates cholesterol metabolism and promotes hepatitis C virus (HCV) replication. Reduced miR-122... 
MICRORNA BINDING | MEDICINE, RESEARCH & EXPERIMENTAL | HEPATOCELLULAR-CARCINOMA | LIPID-METABOLISM | IN-VIVO | GENE-EXPRESSION | MICE | STEATOHEPATITIS | DIFFERENTIATION | HEPATIC STEATOSIS | CANCER | MicroRNAs - therapeutic use | Liver - pathology | Cell Proliferation | MicroRNAs - antagonists & inhibitors | Fatty Liver - pathology | Humans | Cell Survival - genetics | MicroRNAs - metabolism | Liver Neoplasms - therapy | Monocytes - immunology | Genes, myc | Mice, 129 Strain | RNA, Neoplasm - metabolism | Liver Neoplasms, Experimental - metabolism | Liver - immunology | Base Sequence | Carcinoma, Hepatocellular - genetics | Lipids - blood | Monocytes - pathology | Lipid Metabolism - genetics | Liver Neoplasms, Experimental - genetics | 3' Untranslated Regions | Genes, Tumor Suppressor | Neutrophils - pathology | Fatty Liver - genetics | Gene Expression | Fatty Liver - metabolism | Liver Neoplasms - genetics | Liver - metabolism | Neutrophils - immunology | Liver Neoplasms, Experimental - etiology | Mice, Knockout | Animals | Liver Neoplasms - metabolism | RNA, Neoplasm - genetics | Carcinoma, Hepatocellular - therapy | Mice | MicroRNAs - genetics | Cytokines - biosynthesis | Carcinoma, Hepatocellular - metabolism | Fatty Liver - etiology | Liver diseases | MicroRNA | Anti-inflammatory drugs | Tumor necrosis factor | Physiological aspects | Hepatitis C virus | Cholesterol | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology, ISSN 0016-5085, 08/2018, Volume 155, Issue 2, pp. 443 - 457.e17
Little is known about the natural course of nonalcoholic fatty liver disease (NAFLD) with advanced fibrosis. We describe long-term outcomes and evaluate the... 
Gastroesophageal Varices | Nonalcoholic Steatohepatitis | Cryptogenic Cirrhosis | Competing Risk Analysis | PRACTICE GUIDELINE | AMERICAN ASSOCIATION | COMPETING RISKS | NATURAL-HISTORY | ADIPONECTIN LEVELS | EUROPEAN ASSOCIATION | HEPATOCELLULAR-CARCINOMA | CARDIOVASCULAR-DISEASE | CORONARY-HEART-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | SERUM ADIPONECTIN | Non-alcoholic Fatty Liver Disease - pathology | Carcinoma, Hepatocellular - epidemiology | Liver - pathology | Follow-Up Studies | Humans | Middle Aged | Liver Cirrhosis - mortality | Male | Incidence | Liver Neoplasms - etiology | Non-alcoholic Fatty Liver Disease - complications | Liver Neoplasms - epidemiology | Cardiovascular Diseases - epidemiology | Female | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - etiology | Liver - surgery | Non-alcoholic Fatty Liver Disease - surgery | Severity of Illness Index | Cardiovascular Diseases - etiology | Liver Cirrhosis - complications | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Disease Progression | Liver Transplantation - statistics & numerical data | Non-alcoholic Fatty Liver Disease - mortality | Biopsy | Carcinoma, Hepatocellular - pathology | Liver Cirrhosis - pathology | Liver Cirrhosis - surgery | Aged | Fatty liver | Mortality | Analysis | Patient outcomes | Fibrosis | Index Medicus | Abridged Index Medicus
Journal Article